Zyla Health raises funding as part of its Pre- Series A, targets 5X growth in the ongoing year

Zyla Health

Personalised care management startup Zyla Health has raised $1 Mn in fresh funding as part of its Pre-Series A round to accelerate growth. Seeders led the fund-raising round that also saw participation from SuperMorpheus.

Prominent angels including Kavikrut, Chief Growth Officer- Oyo; Rahul Jain, Co-founder & COO- Epigamia; Uday Thakker, Co-founder & Director, Epigamia; Vivek Shah, MD, Investment Banking- Haitong Securities; Mridul Karkara, MD, Monitor Deloitte; Abhishek Shah, Co-founder- Almo; Sumedha Khoche, CEO & Founder- Kinderpass; Amanpreet Singh Bajaj, GM, Airbnb and Udit Goenka, Founder & CEO- PitchGround also participated in the funding round.

Abhishek Rungta, Founder & CEO, Indus Net Technologies and Partner Seeders VC said, “Personalised healthcare dynamics have undergone a dramatic transformation in recent times. Precision, real-time, convenience, and foolproof healthcare management leveraging the best of new-age digital technologies is the need of the hour. Pioneering companies in this domain have immense potential and sky is the limit for such futuristic start-ups. Zyla has quickly made its mark in this landscape and with the accelerated growth pace it has picked, the times ahead appear exciting enough.”

Prior to this fresh raise of funding, Zyla raised capital from leading institutional investors including Kae Capital and Secocha Ventures. The startup is targeting 5X growth this year with the latest infusion of funds.

The inspiration for Zyla Health, however, comes from a rather painful period in the founder, CEO- Khushboo Aggarwal’s personal life, when her father suffered a cardiac event and she realised the gaps that existed in the way healthcare was delivered in India. She left her job to solve for the greater good. The journey started from a one-room office in Delhi, back in 2017.

“We have seen great traction in the last few quarters in our B2B2C model wherein insurers and employers are investing towards the well being of their members/ team through Zyla’s data-driven, highly-utilised products. We continue to strive towards improving healthcare outcomes for people in the most engaging way. Zyla will use the funds to strengthen the leadership and invest in integrating Zyla’s care product across the ecosystem for growth”, said Khushboo Aggarwal Founder & CEO.

The startup claims that in a quick period of time, it has attained the status as India’s highest-rated personalised care management platform focused on improving health outcomes. Zyla enables care at scale for insurers and employers through its human-assisted AI on the 24×7 conversational Zyla app (consistently rated 4.7+). Some of Zyla’s clients include Reserve Bank of India, IOCL, Defsys, 1mg, Aditya Birla, AstraZeneca and Zopper.

Zyla also offers personalised care across a wide spectrum of medical, physical and mental health needs. It starts with a detailed health risk assessment of the population followed by personalised care journeys ranging from chronic disease management to wellness programs.

According to the startup, its proprietary medical AI engine Athena understands causality across multiple data points of patient history and recommends the most personalised intervention to the care team. The chatbot is powered by an advanced NPL that engages with the user in a cognitive conversation, recognises contextual medical queries, and has an in-build advanced escalation system from chatbot to the care team that works in real-time.

The innovation at Zyla makes it available across the ecosystem through agile PWA integration within any master platform.

ABS

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video